RGadbJtkKIHKvKV
¾÷ü¸í | Terrence |
³¯Â¥ | 2020-09-30 ¿ÀÀü 2:10:17 |
Á¶È¸¼ö : 49
US dollars http://truereport.hk/2020/03/%E6%96%B0%E8%81%9E/%E6%B8%AF%E8%81%9E/4340/ buy evista In any case, the analyst said he expects Copaxone sales tofall to about $3.8 billion this year because of competition fromnew oral treatments for multiple sclerosis, including BiogenIdec's Tecfidera and Sanofi SA's Aubagio, andto fall to $3.4 billion in 2014 for the same reason, even if nogenerics are introduced.